Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Mundipharma
Woman and Man
Between 2 years and 18 years
Mundipharma
Update Il y a 4 ans
MUNDIPHARMA BCX1777-108 : Essai de phase 1-2 évaluant la tolérance puis l'efficacité de différents doses de forodesine, chez des patients jeunes ayant un lymphome non hodgkinien à cellules T ou une leucémie aiguë lymphoblastique à cellules B ou T. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
A phase I/II pharmacokinetic study of intravenous and oral forodesine in children with relapsed or refractory T-cell or B-cell precursor acute lymphoblastic leukaemia or T-cell non-hodgkin's lymphoma.
Country
France
organs
Leucémies aiguës
,
Lymphomes non hodgkinien
Specialty
Chimiothérapie
,
Pédiatrie
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Mundipharma Research Ltd
Update Il y a 4 ans
A phase II prospective non-comparative multicenter clinical trial to determine the efficacy and safety of intrathecal liposomal cytarabine (DepoCyte®) in preventing CNS-relapse in patients with aggressive Non-Hodgkin-Lymphomas at risk for CNS metastasis
Incidence of confirmed leptomeningeal metastasis (CNS relapse) during the post treatment observation period of one year verified by CNS cytology
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Mundipharma Research GmbH & Co. KG
Update Il y a 4 ans
A study to demonstrate the improvement in symptoms of constipation in subjects with cancer on non-cancer related pain requiring round the clock opioid therapy
1. To demonstrate that subjects taking OXN PR have improvement in symptoms of constipation as measured by the Bowel Function Index (BFI) compared to subjects taking OxyPR. 2. To demonstrate non-infer...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Mundipharma Research GmbH & Co. KG
Update Il y a 4 ans
A randomised, double-blind, active-controlled, double-dummy, parallel group study to determine the safety and efficacy of oxycodone / naloxone prolonged release tablets in subjects with moderate to severe, chronic cancer pain
To determine the improvement in symptoms of constipation in subjects receiving treatment with oxycodone/naloxone prolonged release tablets (OXN) compared to subjects receiving oxycodone prolonged rele...
Country
None
organs
None
Specialty
None
unknown
More information
Woman Max 99 years
Partly by Mundipharma Pharmaceuticals BV (Netherlands)
Update Il y a 4 ans
Onset of analgesia with OxyNorm Instant in healthy volunteers
Background and study aims Acute and breakthrough pain (sudden additional acute pain on top of the long-term pain) is difficult to treat, especially since the pain requires immediate relief. Various dr...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Mundipharma Research GmbH & Co. KG
Update Il y a 4 ans
Efficacy and Safety in a randomised acute pain study of MR308
To demonstrate the efficacy of MR308 doses in the Treatment of acute moderate to severe pain. Efficacy will be assessed by showing superiority of MR308 doses over Placebo and non-inferiority compared ...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Mundipharma Research GmbH & Co. KG
Update Il y a 4 ans
A study to evaluate the effect and tolerability of laxatives (medicines against constipation) for the reversal of constipation caused by opioids (medicines against pain)
Primary Objective •To assess the effect of SLT on the frequency of soft (stool of type 3, 4 or 5 on the Bristol Stool Form Scale (BSFS)) complete bowel movements (SCBMs) per week in subjects taking W...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Mundipharma Pharmaceuticals B.V
Update Il y a 4 ans
A clinical study to investigate the infliximab serum concentration of Remsima™ (infliximab biosimilar) after switching from Remicade (infliximab) in subjects with Crohn’s Disease (CD), Ulcerative Colitis (UC) or Rheumatoid Arthritis (RA) in stable remission. Een klinische studie om de concentratie Remsima™ (infliximab biosimilar) in het bloed te onderzoeken nadat patiënten met de ziekte van Crohn, Colitis Ulcerosa of Reumatoïde Artritis in remissie zijn omgeschakeld van Remicade (infliximab)
To demonstrate that the infliximab serum concentration of Remsima™ is non-inferior to the infliximab serum concentration of Remicade , 16 weeks after switch from Remicade to Remsima™ in subjects with ...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Mundipharma China Ltd
Update Il y a 4 ans
Oxycodone Hydrochloride Injection in the Postoperative Pain Relieving Treatment
To determine the efficacy and safety of oxycodone i.v. patient-controlled analgesia (PCA) in the pain relieving treatment during 48h postoperative period, by comparing with morphine i.v. P...
Country
China
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Mundipharma OY
Update Il y a 4 ans
A randomised, double-blind, parallel group multicenter study to demonstrate non-inferiority of the analgesic efficacy of oxycodone/naloxone 10/5 or 20/10 mg prolonged release tablets (OXN PR) BID compared to oxycodone 10 or 20 mg prolonged release tablets (OXY PR) BID in subjects with postoperative pain after knee arthroplasty
• To demonstrate that treatment with OXN PR tablets is non-inferior to treatment with OXY PR tablets in terms of analgesic efficacy in patients with postoperative pain after knee arthroplasty based on...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
1
2
3
4
Next